Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia. Electronic address: https://twitter.com/anant_butala.
Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia; Department of Cardiology, Cabrini Hospital, Melbourne, Vic, Australia; Department of Cardiology, Epworth Hospital, Melbourne, Vic, Australia. Electronic address: https://twitter.com/DrNanayakkara.
Heart Lung Circ. 2024 Mar;33(3):316-323. doi: 10.1016/j.hlc.2023.11.018. Epub 2024 Jan 19.
Acute kidney injury (AKI) is a known complication following transcatheter aortic valve implantation (TAVI), associated with increased morbidity and mortality. Most of this data relates to higher-risk patients with early-generation TAVI valves. With TAVI now established as a safe and cost-effective procedure for low-risk patients, there is a distinct need for updated analysis. We aimed to assess the incidence, predictors, and outcomes of AKI in a contemporary cohort of TAVI patients, concurrently examining the role of temporal evolution on AKI.
A total of 2,564 patients undergoing TAVI from 2008-2023 included in the Alfred-Cabrini-Epworth (ACE) TAVI Registry were analysed. Patients were divided into AKI and no AKI groups. Outcomes were reported according to the Valve Academic Research Consortium-3 (VARC-3) criteria.
Of 2,564 patients, median age 83 (78-87) years, 57.4% men and a median Society of Thoracic Surgeons score of 3.6 (2.4-5.5), 163 (6.4%) patients developed AKI with incidence falling from 9.7% between 2008-2014 to 6% between 2015-2023 (p=0.022). On multivariable analysis, independent predictors of AKI were male sex (adjusted odds ratio [aOR] 1.89, p=0.005), congestive cardiac failure (aOR 1.52, p=0.048), estimated glomerular filtration rate 30-59 (aOR: 2.79, p<0.001), estimated glomerular filtration rate <30 (aOR 8.65, p<0.001), non-femoral access (aOR 5.35, p<0.001), contrast volume (aOR 1.01, p<0.001), self-expanding valve (aOR 1.60, p=0.045), and bleeding (aOR 2.88, p=0.005). Acute kidney injury was an independent predictor of 30-day (aOR: 6.07, p<0.001) and 12-month (aOR: 3.01, p=0.002) mortality, an association that remained consistent when excluding TAVIs performed prior to 2015.
Acute kidney injury remains a relatively common complication of TAVI, associated with significant morbidity and mortality even in less comorbid, contemporary practice patients.
急性肾损伤(AKI)是经导管主动脉瓣植入(TAVI)后的已知并发症,与发病率和死亡率增加有关。大多数此类数据与使用早期一代 TAVI 瓣膜的高危患者有关。随着 TAVI 已成为低危患者安全且具有成本效益的手术,因此非常需要进行最新的分析。我们旨在评估当代 TAVI 患者队列中 AKI 的发生率、预测因素和结局,同时检查 AKI 时间演变的作用。
分析了 2008 年至 2023 年期间在阿尔弗雷德-卡布里尼-埃普沃思(ACE)TAVI 注册中心接受 TAVI 的 2564 例患者。患者分为 AKI 组和无 AKI 组。根据 Valve Academic Research Consortium-3(VARC-3)标准报告结局。
在 2564 例患者中,中位年龄为 83(78-87)岁,57.4%为男性,中位胸外科医生协会评分 3.6(2.4-5.5),163(6.4%)例患者发生 AKI,发生率从 2008-2014 年的 9.7%下降到 2015-2023 年的 6%(p=0.022)。多变量分析显示,AKI 的独立预测因素为男性(调整优势比[aOR]1.89,p=0.005)、充血性心力衰竭(aOR 1.52,p=0.048)、估计肾小球滤过率 30-59(aOR:2.79,p<0.001)、估计肾小球滤过率<30(aOR 8.65,p<0.001)、非股动脉入路(aOR 5.35,p<0.001)、造影剂体积(aOR 1.01,p<0.001)、自膨式瓣膜(aOR 1.60,p=0.045)和出血(aOR 2.88,p=0.005)。AKI 是 30 天(aOR:6.07,p<0.001)和 12 个月(aOR:3.01,p=0.002)死亡率的独立预测因素,即使在合并症较少的当代患者中,这种关联仍然一致。
急性肾损伤仍然是 TAVI 的一个相对常见的并发症,即使在合并症较少的当代患者中,也与显著的发病率和死亡率相关。